REFERENCES
- McGregor JA, French JI, Parker R, et at. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 1995; 173:157–66
- Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC (No. RR-II). MMWR 2002;51
- McDonald HM, O'Loughlin JA, Jolley P, et at. Prenatal microbiological risk factors associated with preterm birth. Br J Obstet Gynaecol 1992; 99:190–6
- Gibbs RS, Romero R, Hillier SL, et at. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992;166:1515–28
- Yoon BH, Chang JW, Romero R, et at. Isolation of Ureaplasma uraeliticum from the amniotic cavity and adverse outcome in preterm labor. Obstet Gynecol 1998; 92:77–82
- Donders GGG, Van Buick B, Caudron J, et at. Relationship of bacterial vaginosis and mycoplasmas to the risk of sponta-neous abortion. Am J Obstet Gynecol 2000; 183:431–7
- Leitich H, Bodner-Adler B, Brunbauer M, et at. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 2003;189:139–47
- Goffinet F, Maillard F, Mihoubi N, et at. Bacterial vaginosis: prevalence and predictive value for premature delivery and neonatal infection in women with preterm labour and intact membranes. Eur J Obstet Gynaecol Reprod Biol 2003;108: 146–51
- Carey JC, Klebanoff MA. What have we learned about vaginal infections and preterm birth? Semin Perinatol 2003;27:212–16
- Leitich H, Brunbauer M, Bodner-Adler B, et at. Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis. Am J Obstet Gynecol 2003;188:752–8